Medication info
Telmione Plus Tablet 40/12.5 mg

Telmione Plus Tablet 40/12.5 mg

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›40mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
HK inno.N Co., Ltd.
Appearance
Oval-shaped tablet with a white/pink two-layer structure, where the white layer may have pink spots.
Packaging
30 tablets/box (10 tablets/Alu-Alu X 3)
Approval status
Active

MFDS item code 201005774 · Notified 2010.09.30 · Insurance code 640005940

Summary

Main use
Treatment of essential hypertension not adequately controlled with telmisartan alone
Who takes it
Adults · Children
Adult dose
Take once daily with a drink, regardless of meals, in patients whose blood pressure is not adequately controlled with telmisartan alone. Before switching to this medicine, which contains fixed doses of each component, it is recommended that the dose of each component be adjusted individually. When clinically appropriate, direct switching from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg given as separate products or as a combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dose adjustment is necessary in patients with mild-to-moderate renal impairment. Do not administer this medicine to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment This medicine should be administered with caution to patients with mild-to-moderate hepatic impairment. Do not administer more than 40/12.5mg of this medicine per day. Do not administer this medicine to patients with severe hepatic impairment (see Precautions for Use 2.). Thiazide diuretics should be administered with caution to patients with impaired liver function. Elderly patients No dose change is necessary.
Child dose
The safety and efficacy of this medicine have not been established in children under 18 years of age.

Ingredients

Manufacturer
HK inno.N Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not adequately controlled with telmisartan alone

  • Essential hypertension
View approved original text

This medication is used for the treatment of essential hypertension. It is administered additionally to patients whose blood pressure is not adequately controlled with Telmisartan alone, helping to manage blood pressure effectively. This contributes to lowering blood pressure reliably and reducing the risk of complications associated with hypertension.

How to take

Adult dose

Take once daily with a drink, regardless of meals, in patients whose blood pressure is not adequately controlled with telmisartan alone. Before switching to this medicine, which contains fixed doses of each component, it is recommended that the dose of each component be adjusted individually. When clinically appropriate, direct switching from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg given as separate products or as a combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dose adjustment is necessary in patients with mild-to-moderate renal impairment. Do not administer this medicine to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment This medicine should be administered with caution to patients with mild-to-moderate hepatic impairment. Do not administer more than 40/12.5mg of this medicine per day. Do not administer this medicine to patients with severe hepatic impairment (see Precautions for Use 2.). Thiazide diuretics should be administered with caution to patients with impaired liver function. Elderly patients No dose change is necessary.

Child dose

The safety and efficacy of this medicine have not been established in children under 18 years of age.

Precautions

This medication should not be used during pregnancy, especially in the second and third trimesters, as it can cause serious harm to the fetus. It should not be administered to patients who are allergic to the ingredients or excipients, pregnant or breastfeeding women, patients with severe liver or kidney disease, and those with certain electrolyte abnormalities. Elderly patients or those with high serum potassium levels, impaired liver function, or cardiovascular diseases should use this medication with caution. This medication can cause various adverse reactions, with common symptoms including dizziness, hypotension, diarrhea, and rash, while serious skin reactions or renal dysfunction may occur rarely. The component Telmisartan is primarily excreted by the liver; therefore, it is contraindicated in patients with severely impaired liver function, and this medication should not be used in patients with severely impaired kidney function. Patients with fluid or sodium deficiency may experience a rapid drop in blood pressure initially; hence caution is necessary. This medication can interact with other antihypertensives, lithium, potassium supplements, non-steroidal anti-inflammatory drugs, etc., so patients should consult a physician or pharmacist if they are taking any other medications. Women planning pregnancy are advised to switch to a safer antihypertensive treatment instead, and if pregnancy is confirmed, this medication should be discontinued immediately. Breastfeeding women are advised not to take this medication, as it can be secreted in breast milk and affect the baby. In case of overdose, symptoms such as hypotension, electrolyte imbalances, and dehydration may occur, requiring immediate medical attention. This medication is not recommended for pediatric patients under 18 years of age, as its safety and efficacy have not been established. Drowsiness or dizziness may occur during treatment; thus, it is advisable to avoid driving or operating dangerous machinery. This medication can cause photosensitivity, so patients should take precautions against UV exposure while on this medication.

Side effects

  • Bronchitis
  • pharyngitis
  • sinusitis
  • hypokalemia
  • hyperuricemia
  • hyponatremia
  • anxiety
  • depression
  • insomnia
  • sleep disorders
Show 121 more
  • dizziness
  • fainting
  • paresthesia
  • visual impairment
  • blurred vision
  • vertigo
  • tachycardia
  • arrhythmia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • respiratory distress
  • pneumonia
  • pulmonary edema
  • diarrhea
  • dry mouth
  • abdominal distension
  • abdominal pain
  • constipation
  • dyspepsia
  • vomiting
  • gastritis
  • abnormal liver function
  • liver disorders
  • vascular edema
  • erythema
  • pruritus
  • rash
  • hyperhidrosis
  • urticaria
  • back pain
  • muscle spasms
  • myalgia
  • arthralgia
  • limb pain
  • systemic lupus erythematosus
  • erectile dysfunction
  • chest pain
  • influenza-like illness
  • pain
  • increased blood uric acid
  • increased blood creatinine
  • increased serum creatine phosphokinase
  • increased liver enzymes
  • upper respiratory tract infection
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • eosinophilia
  • thrombocytopenia
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • drowsiness
  • cough
  • dry mouth
  • abdominal discomfort
  • eczema
  • drug rash
  • toxic epidermal necrolysis
  • bone pain
  • renal dysfunction
  • asthenia
  • influenza-like illness
  • increased serum creatine phosphokinase
  • decreased hemoglobin
  • sialadenitis
  • nonmelanoma skin cancer
  • thrombocytopenic purpura
  • hemolytic anemia
  • bone marrow failure
  • leukopenia
  • agranulocytosis
  • hypersensitivity
  • aplastic anemia
  • decreased appetite
  • hypomagnesemia
  • hyperglycemia
  • hypercalcemia
  • hypochloremic metabolic alkalosis
  • yellow vision
  • acute myopia
  • angle-closure glaucoma
  • choroidal effusion
  • necrotizing vasculitis
  • acute respiratory distress syndrome
  • nausea
  • pancreatitis
  • jaundice
  • cholestasis
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • lupus-like syndrome
  • systemic lupus erythematosus
  • acute renal failure
  • diabetes
  • asthenia
  • fever
  • dizziness
  • itching
  • myalgia
  • headache
  • floaters
  • nausea
  • gastrointestinal bleeding
  • esophagitis
  • gastritis
  • headache
  • tremor
  • flushing
  • malaise
  • fatigue
  • weight loss
  • proteinuria
  • lip tremor and hand tremor
  • sensory hypersensitivity
  • visual impairment
  • hypotension
  • tachycardia
  • bradycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to avoid exposure to air or moisture. It is recommended to maintain the storage temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

Oval-shaped tablet with a white/pink two-layer structure, where the white layer may have pink spots.

Package unit

30 tablets/box (10 tablets/Alu-Alu X 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.